Department of Internal Medicine (Gastroenterology and Hepatology)

Medicine & Life Sciences

1. Ulcerative Colitis 100%
2. Crohn Disease 60%
3. Helicobacter pylori 52%
4. Japan 48%
5. Inflammatory Bowel Diseases 48%
6. Colitis 39%
7. Endoscopic Mucosal Resection 34%
8. Stomach 29%
9. Organoids 29%
10. Therapeutics 27%
11. Liver 25%
12. Pancreatitis 24%
13. Colonoscopy 22%
14. Neoplasms 22%
15. Confidence Intervals 21%
16. Mucous Membrane 21%
17. Macrophages 20%
18. Liver Cirrhosis 20%
19. Stomach Neoplasms 20%
20. Inflammation 20%
21. Multicenter Studies 19%
22. Adalimumab 18%
23. Capsule Endoscopy 18%
24. T-Lymphocytes 18%
25. Hemorrhage 18%
26. Autoimmune Hepatitis 18%
27. Odds Ratio 18%
28. Coronavirus 18%
29. Colon 16%
30. Gastrointestinal Microbiome 16%
31. Dyspepsia 15%
32. Non-alcoholic Fatty Liver Disease 15%
33. Interferons 15%
34. Endoscopy 14%
35. Indigo Carmine 14%
36. Fatty Liver 14%
37. Meta-Analysis 14%
38. Hepatic Stellate Cells 13%
39. Liver Diseases 13%
40. Recurrence 13%
41. Helicobacter Infections 13%
42. Safety 12%
43. Chronic Hepatitis C 12%
44. Infliximab 12%
45. Autoimmune Pancreatitis 12%
46. Mesalamine 12%
47. vedolizumab 11%
48. Cohort Studies 11%
49. Fibrosis 11%
50. Lymphocytes 11%
51. Mutation 11%
52. Fecal Microbiota Transplantation 11%
53. Serum 10%
54. Systematic Reviews 10%
55. Adenoma 10%
56. Colorectal Neoplasms 10%
57. Intestinal Diseases 10%
58. Metronidazole 10%
59. sitafloxacin 10%
60. Feasibility Studies 10%
61. Small Intestine 10%
62. Single-Balloon Enteroscopy 10%
63. Pancreatic Neoplasms 10%
64. Retrospective Studies 10%
65. Advisory Committees 9%
66. Cytokines 9%
67. Acute Liver Failure 9%
68. Pylorus 9%
69. Genes 9%
70. Dendritic Cells 9%
71. Adenocarcinoma 9%
72. Observational Studies 9%
73. Prospective Studies 9%
74. Th17 Cells 8%
75. Steroids 8%
76. Intestines 8%
77. Randomized Controlled Trials 8%
78. Interleukin-7 8%
79. Apoptosis 8%
80. Placebos 8%
81. Th1 Cells 8%
82. Infections 8%
83. Ghrelin 8%
84. Clarithromycin 8%
85. Gastroenterology 8%
86. Proton Pump Inhibitors 8%
87. Microbiota 8%
88. Tumor Necrosis Factor-alpha 8%
89. Biopsy 8%
90. Hepatocellular Carcinoma 8%
91. Intestinal Mucosa 8%
92. Ribavirin 8%
93. Incidence 8%
94. Atrophy 7%
95. Interleukin-10 7%
96. Hepatitis 7%
97. Wounds and Injuries 7%
98. Budesonide 7%
99. Amoxicillin 7%
100. Obesity 7%